Look for:

Our offer for

WUXI BIOLOGICS (CAYMAN) INC.


ISIN:
KYG970081173
WKN:
-

2024/04/26 22:26:46
Price
1.6326 EUR
Difference 8.18% (0.12)

General attributes

ISINKYG970081173
Symbol2269
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)6,859 EUR
BenchmarkMSCI WORLD INDEX (STRD, UHD)

Market data

Bid (Bid size)1.6012 EUR (1,392)
Ask (Ask size)1.6642 EUR (1,338)
Open1.587 EUR
High1.65 EUR
Low1.587 EUR
Close (prev. day)1.5092 EUR
VWAP1.6253 EUR
Volume (pcs)9,200
Trading volume14,952.75
Number of trades10
Last size-

Futures and Options

Related Futures-
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research

Date Headline Download
2024/04/26 en Global Equity Ratings PDF Download
2024/04/03 en Global Equity Ratings PDF Download
2024/03/13 en Global Equity Ratings PDF Download
2024/02/22 en Global Equity Ratings PDF Download
2024/02/14 en Global Equity Ratings PDF Download


2024/04/26 22:26:46
Price
1.6326 EUR
Difference 8.18% (0.12)

General attributes

ISINKYG970081173
Symbol2269
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)6,859 EUR
BenchmarkMSCI WORLD INDEX (STRD, UHD)

Market data

Bid (Bid size)1.6012 EUR (1,392)
Ask (Ask size)1.6642 EUR (1,338)
Open1.587 EUR
High1.65 EUR
Low1.587 EUR
Close (prev. day)1.5092 EUR
VWAP1.6253 EUR
Volume (pcs)9,200
Trading volume14,952.75
Number of trades10
Last size-

Performance and Risk

6m1Y3Y
Perf (%)-69.33%-69.44%-86.02%
Perf (abs.)-3.73-3.75-10.15
Beta0.790.980.65
Volatility85.3271.0168.95
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)1.5600 EUR (3,635)
Ø price 30 days | Ø volume 30 days (pcs.)1.6459 EUR (8,184)
Ø price 100 days | Ø volume 100 days (pcs.)2.4740 EUR (11,244)
Ø price 250 days | Ø volume 250 days (pcs.)4.1042 EUR (6,127)
YTD High | date3.6720 EUR (2024/01/11)
YTD Low | date1.4930 EUR (2024/04/19)
52 Weeks High | date6.1900 EUR (2023/11/08)
52 Weeks Low | date1.4930 EUR (2024/04/19)

All listings for WUXI BIOLOGICS (CAYMAN) INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/04/2622:261.6326 EUR0.0110
Stuttgart2024/04/2614:331.6226 EUR0.005
Munich2024/04/2608:111.5776 EUR0.002
Hong Kong Stock Exchange2024/04/2610:0813.48 HKD--
Frankfurt2024/04/2614:041.6402 EUR0.001
FINRA other OTC Issues2024/04/2620:281.68 USD0.011
Duesseldorf2024/04/2619:301.5976 EUR0.007
Berlin2024/04/2621:051.635 EUR0.008

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=143050&ID_TYPE_IMAGE_LOGO=2

Contact Details

WUXI BIOLOGICS (CAYMAN) INC.
- -
- - - -
Telefon: -
Fax: -
E-mail: -

Company Profile

-

Members of Management Board

Zhisheng (Chris) Chen, Ph.D.Chairman of Managing Board
Christine Lu-WongMember of Executive Committee
Jijie Gu, Ph.D.Member of Executive Committee
Weichang Zhou, Ph.D.Member of Executive Committee

Board of directors

Ge LiChairman of Supervisory Board
Jue ChenMember of Supervisory Board
Weichang ZhouMember of Supervisory Board
Yi Bing WuMember of Supervisory Board
Jackson TaiMember of Supervisory Board
Kenneth HitchnerMember of Supervisory Board
William KellerMember of Supervisory Board
Yan Ling CaoMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer